Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: A retrospective analysis

被引：0
|
作者：
Sheashaa, Hussein [1 ]
Fouda, Mohamed Ashraf [1 ]
Bakr, Mohamed Adel [1 ]
Sobh, Mohamed [1 ]
Ismail, Amany [1 ]
Ghoneim, Mohamed [1 ]
机构：
[1] Urol & Nephrol Ctr, Mansoura, Egypt
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：266 / 266
页数：1
相关论文
共 50 条
  • [11] Thymoglobulin Versus Basiliximab Induction Therapy for Simultaneous Kidney-Pancreas Transplantation: Impact on Rejection, Graft Function, and Long-Term Outcome
    Bazerbachi, Fateh
    Selzner, Markus
    Boehnert, Markus U.
    Marquez, Max A.
    Norgate, Andrea
    McGilvray, Ian D.
    Schiff, Jeffrey
    Cattral, Mark S.
    TRANSPLANTATION, 2011, 92 (09) : 1039 - 1043
  • [12] Basiliximab or Antithymocyte Globulin for Induction Therapy in Kidney Transplantation: A Meta-analysis
    Liu, Y.
    Zhou, P.
    Han, M.
    Xue, C-B
    Hu, X-P
    Li, C.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (05) : 1667 - 1670
  • [13] LONG-TERM OUTCOME OF INDUCTION IMMUNOSUPPRESSION USING ANTI-THYMOCYTE GLOBULIN VERSUS BASILIXIMAB IN KIDNEY TRANSPLANTATION
    Mohamed, Taher F.
    Ehab, Wafa W.
    Yasser, Moniem El Hendy
    Tamer, Goda M.
    Mohamed, Mashaly
    Ahmed, Denewar
    TRANSPLANT INTERNATIONAL, 2017, 30 : 562 - 563
  • [14] Long-term evaluation of neuromyopathy in live donor FMF amyloidotic kidney transplant recipients
    Sherif, AM
    Refaie, AF
    Sheashaa, HA
    El-Tantawy, AE
    Sobh, MA
    AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (06) : 582 - 586
  • [15] LONG-TERM RESULTS OF LIVING DONOR KIDNEY TRANSPLANTATION
    Akdur, Aydincan
    Karakayali, Feza Yarbug
    Caliskan, Kenan
    Moray, Gokhan
    Arslan, Gulnaz
    Haberal, Mehmet A.
    TRANSPLANTATION, 2020, 104 (09) : S409 - S409
  • [16] Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up
    Hussein A. Sheashaa
    Mohamed A. Bakr
    Mohamed Ashraf Fouda
    Khalid F. El-dahshan
    Amany M. Ismail
    Mohamed A. Sobh
    Mohamed A. Ghoneim
    International Urology and Nephrology, 2007, 39 : 317 - 319
  • [17] Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up
    Sheashaa, Hussein A.
    Bakr, Mohamed A.
    Fouda, Mohamed Ashraf
    El-Dahshan, Khalid F.
    Ismail, Amany M.
    Sobh, Mohamed A.
    Ghoneim, Mohamed A.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2007, 39 (01) : 317 - 319
  • [18] The effect of induction therapy with basiliximab on acute rejection in living donor liver transplantation (LDLT) (retrospective study).
    Safwat, Wael
    Refaie, Rasha
    Mostafa, Ibrahim
    Abdel-Aal, Medhat
    El-Monieri, Magda
    El-Metient, Mahmoud
    Fathy, Mohamed
    LIVER TRANSPLANTATION, 2007, 13 (06) : S72 - S73
  • [19] Multivariate analysis of antibody induction therapy and their associated outcomes in live donor kidney transplantation in the recent era
    Emami, Sina
    Huang, Edmund
    Kuo, Hung-Tien
    Kamgar, Mohammad
    Bunnapradist, Suphamai
    CLINICAL TRANSPLANTATION, 2012, 26 (02) : 351 - 358
  • [20] Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial
    Favi, E.
    Silvestrini, N.
    Spagnoletti, G.
    Castagneto, M.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 147 - 147
12345